Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D

Published byAngelina Peters Modified over 6 years ago

Similar presentations

Presentation on theme: "Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D"— Presentation transcript:

1 Proton therapy for prostate cancer: the initial Loma Linda University experience 
Jerry D Slater, M.D., Carl J Rossi, M.D., Les T Yonemoto, M.D., David A Bush, M.D., B.Rodney Jabola, M.D., Richard P Levy, M.D., Ph.D., Roger I Grove, M.P.H., William Preston, Ed.D., James M Slater, M.D., F.A.C.R.  International Journal of Radiation Oncology • Biology • Physics  Volume 59, Issue 2, Pages (June 2004) DOI: /j.ijrobp

2 Fig. 1 Biochemical disease-free survival. The numbers represent number of patients at risk. International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

3 Fig. 2 Effect of initial prostate-specific antigen on biochemical disease-free survival. International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

4 Fig. 3 Gleason grade in relation to biochemical disease-free survival.
International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

5 Fig. 4 Effect of prostate-specific antigen nadir levels on biochemical disease-free survival. International Journal of Radiation Oncology • Biology • Physics  , DOI: ( /j.ijrobp )

Download ppt "Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D"

Similar presentations

A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time Emma Liu, MM, Pablo Santibáñez, MM, Martin L. Puterman, PhD,

A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time Emma Liu, MM, Pablo Santibáñez, MM, Martin L. Puterman, PhD,
125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy  Mira Keyes, MD, Tom Pickles, MD, Alexander Agranovich, MD, Winkle.

125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy  Mira Keyes, MD, Tom Pickles, MD, Alexander Agranovich, MD, Winkle.
Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.
Jessica L. Conway, MD, Joseph M

Jessica L. Conway, MD, Joseph M
Chris H. J. Terhaard, M. D. , Ph. D. , Herman Lubsen, M. D. , Ph. D

Chris H. J. Terhaard, M. D. , Ph. D. , Herman Lubsen, M. D. , Ph. D
COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.
The Case for Prostate Brachytherapy in the Affordable Care Act Era

The Case for Prostate Brachytherapy in the Affordable Care Act Era
Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer  Thomas J. Pugh, MD, Mark F.

Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer  Thomas J. Pugh, MD, Mark F.
The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation.

The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation.
A Double-Blind Placebo-Controlled Randomized Clinical Trial With Magnesium Oxide to Reduce Intrafraction Prostate Motion for Prostate Cancer Radiotherapy 

A Double-Blind Placebo-Controlled Randomized Clinical Trial With Magnesium Oxide to Reduce Intrafraction Prostate Motion for Prostate Cancer Radiotherapy 
The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study  Alan M. Nichol,

The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study  Alan M. Nichol,
Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer 

Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer 
Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From.

Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From.
18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 
Dose-Volume Histogram Predictors of Chronic Gastrointestinal Complications After Radical Hysterectomy and Postoperative Concurrent Nedaplatin-Based Chemoradiation.

Dose-Volume Histogram Predictors of Chronic Gastrointestinal Complications After Radical Hysterectomy and Postoperative Concurrent Nedaplatin-Based Chemoradiation.
The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012  Geoff P. Delaney,

The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012  Geoff P. Delaney,
Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma  Q. Le, A.

Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma  Q. Le, A.
Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.
Individualized Positron Emission Tomography–Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy:

Individualized Positron Emission Tomography–Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy:

Similar presentations

Ads by Google